2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Zhonghua xin xue guan bing za zhi - 48(2020), 7 vom: 24. Juli, Seite 532-538 |
| Sprache: |
Chinesisch |
|---|
| Beteiligte Personen: |
Shi, H Z [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ACE2 protein, human |
|---|
| Anmerkungen: |
Date Completed 09.09.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3760/cma.j.cn112148-20200308-00171 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM307550516 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM307550516 | ||
| 003 | DE-627 | ||
| 005 | 20231225125817.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||chi c | ||
| 024 | 7 | |a 10.3760/cma.j.cn112148-20200308-00171 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1025.xml |
| 035 | |a (DE-627)NLM307550516 | ||
| 035 | |a (NLM)32166940 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 100 | 1 | |a Shi, H Z |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.09.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Angiotensin Receptor Antagonists |2 NLM | |
| 650 | 7 | |a Cardiovascular Agents |2 NLM | |
| 650 | 7 | |a Peptidyl-Dipeptidase A |2 NLM | |
| 650 | 7 | |a EC 3.4.15.1 |2 NLM | |
| 650 | 7 | |a ACE2 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 700 | 1 | |a Ma, P |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, F Y |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, G L |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Y H |e verfasserin |4 aut | |
| 700 | 1 | |a Xian, X D |e verfasserin |4 aut | |
| 700 | 1 | |a Dong, E D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zhonghua xin xue guan bing za zhi |d 1993 |g 48(2020), 7 vom: 24. Juli, Seite 532-538 |w (DE-627)NLM000466050 |x 0253-3758 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2020 |g number:7 |g day:24 |g month:07 |g pages:532-538 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3760/cma.j.cn112148-20200308-00171 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2020 |e 7 |b 24 |c 07 |h 532-538 | ||